Search Results

Humanitarian Goals, Financial Constraints, and Residual Questions of America's First Vaccine Institute.

• Authors : Rusnock A; Andrea Rusnock is with the Department of History, University of Rhode Island, Kingston.

Subjects: Medicine* ; Vaccines*; Academies and Institutes

• Source: American journal of public health [Am J Public Health] 2018 Jun; Vol. 108 (6), pp. 715-717.Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print Cited Medium: Internet

Record details

In silico design of multi-epitope vaccines against the hantaviruses by integrated structural vaccinology and molecular modeling approaches.

• Authors : Ali, Liaqat¹ (AUTHOR) ; Rauf, Sobiah¹ (AUTHOR); Khan, Abbas² (AUTHOR)

Subjects: *HEMORRHAGIC fever with renal syndrome; *HANTAVIRUSES; *IMMUNOGLOBULIN M

• Source: PLoS ONE. 7/23/2024, Vol. 19 Issue 7, p1-20. 20p.

Record details

Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus.

• Authors : Oladipo, Elijah Kolawole^1,2 (AUTHOR); Ojo, Taiwo Ooreoluwa^1,3 (AUTHOR); Elegbeleye, Oluwabamise Emmanuel³ (AUTHOR)

• Source: Scientific Reports. 7/22/2024, Vol. 14 Issue 1, p1-22. 22p.

Record details

Vacunación en menores de cinco años.

• Authors : Mongua-Rodríguez, Norma¹; Delgado-Sánchez, Guadalupe¹; Ferreira-Guerrero, Elizabeth¹

• Source: Salud Pública de México. jul/ago2024, Vol. 66 Issue 4, p368-380. 13p.

Record details

Bactericidal Activity of Serum by Brucella Abortus RB51 Outer Membrane Protein's Combined by Brucella Abortus S99 Lipopolysaccharide Induction.

• Authors : Sisakht, Behnam Hajizadeh¹; Khaledi, Mansoor²; Afkhami, Hamed³

• Source: Avicenna Journal of Medical Biotechnology. Jul-Sep2024, Vol. 16 Issue 3, p187-192. 6p.

Record details

Comparison of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Antibody Response by Different Vaccine Combinations.

• Authors : Muhtaroğlu, Sabahattin¹; Keti, Didem Barlak¹ ; Başkol, Gülden¹

• Source: Journal of Clinical Practice & Research. Jul2024, Vol. 46 Issue 4, p347-353. 7p.

Record details

Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity.

• Authors : Viravathana, Polrit¹ (AUTHOR); Tepp, William H.¹ (AUTHOR); Bradshaw, Marite¹ (AUTHOR)

Subjects: *ESCHERICHIA coli; *BOTULISM; *AMINO acids

• Source: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8955. 18p.

Record details

Prevalence and factors associated with hepatitis B susceptibility among men who sex with men on HIV pre-exposure prophylaxis in Northeastern Brazil: a cross-sectional study.

• Authors : Vechi, Hareton Teixeira¹ (NURSE) ; de Freitas, Cláudio Henrique Silva¹ (NURSE); de Lira Nunes Paulino, Fernanda¹ (NURSE)

• Source: BMC Infectious Diseases. 8/8/2024, Vol. 24 Issue 1, p1-12. 12p.

Record details

Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology.

• Authors : Hampson, Ian N.¹ (AUTHOR) ; Oliver, Anthony W.² (AUTHOR)

Subjects: *VACCINE effectiveness; *CERVICAL intraepithelial neoplasia; *HUMAN papillomavirus

• Source: Viruses (1999-4915). Aug2024, Vol. 16 Issue 8, p1245. 11p.

Record details

Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.

• Authors : Sadones, Océane¹ (AUTHOR) ; Kramarska, Eliza² (AUTHOR); Laverde, Diana¹ (AUTHOR)

Subjects: *ENTEROCOCCUS; *ENTEROCOCCUS faecium; *PROTEOMICS

• Source: BMC Microbiology. 7/27/2024, Vol. 24 Issue 1, p1-13. 13p.

Record details